C. diff
How Have FDA Approvals Changed the Landscape of Microbiome Therapeutics?
At DDW 2024, Jessica Allegretti, MD, MPH, described new treatments for recurrent C. difficile and how she ...
AUGUST 19, 2024
AGA Offers New Guidance on FMT Therapies To Prevent C. diff
Treatment with FMT is effective for preventing recurrent C. diff infection in adults with robust immune systems, ...
APRIL 20, 2024
Elena Ivanina, DO, MPH, on Incorporating Holistic Care Into Practice
Dr. Ivanina sat down with GEN’s Sarah Tilyou to discuss how the microbiome comes into play in her practice ...
OCTOBER 6, 2023
FDA Approves First Orally Administered Fecal Microbiota Product to Prevent C. diff Recurrence
The FDA approved the first fecal microbiota product that is taken orally to prevent recurrent CDI in people who are ...
APRIL 28, 2023
More Americans Dying From Resistant Infections Than Previously Thought
The CDC issued a report today indicating that antibiotic-resistant bacteria and fungi cause more than 2.8 million ...
FEBRUARY 7, 2020
Controversy Continues on Open-Label FMT for Resistant C. diff
The FDA held another meeting to discuss the safety of making FMT available to patients before an approved product ...
NOVEMBER 6, 2019
Pharmacologic Therapy To Manage CDI
A number of pharmacologic therapies are available or in clinical development to treat Clostridioides difficile ...
OCTOBER 15, 2019
